ClinConnect ClinConnect Logo
Search / Trial NCT03787875

Impact of Periodontal Treatment on the RANKL/OPG Ratio in Crevicular Fluid

Launched by UNIVERSITY OF VALENCIA · Dec 24, 2018

Trial Information

Current as of May 21, 2025

Completed

Keywords

Rankl Opg Periodontal Biomarkers Alveolar Bone Loss Chronic Periodontitis

ClinConnect Summary

Material and methods Study design A case-control study was proposed. A group of periodontally healthy subjects was compared to a group of patients with periodontitis before and after scaling and root planing.

Two sites were studied in each subject with periodontitis: one affected site (with periodontitis) and one healthy site (without periodontal disease); the latter site served as a control. Thus, the study units were the healthy and pathological sites before and after SRP treatment.

The masking was triple blind, including the researcher in charge of sample collection, the laboratory tec...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. -The control group included:
  • 10 periodontally healthy subjects
  • Without signs or symptoms of periodontal disease.
  • 2. -The study group included:
  • 15 subjects diagnosed with mild or advanced chronic periodontitis.
  • One non-affected single-rooted tooth (healthy site)
  • Single-rooted tooth with periodontitis (periodontitis site) with the following features: with clinical attachment loss equal to or greater than 6 mm and bleeding upon probing.
  • Exclusion Criteria:
  • Subjects with aggressive periodontitis
  • Systemic diseases or consumption of drugs affecting bone metabolism
  • Antibiotic, anti-inflammatory or contraceptive treatment for the last three months prior to study initiation
  • Antiplatelet therapy for the last 7 days prior to study onset
  • Primary or secondary occlusal trauma
  • Periapical or periodontal abscess in some of the teeth included in the study
  • Periodontal treatment within the last 6 months
  • Orthodontic treatment
  • Smoking
  • Pregnant or breastfeeding.

About University Of Valencia

The University of Valencia, a prestigious institution located in Spain, is dedicated to advancing scientific knowledge and improving public health through innovative research. With a strong emphasis on interdisciplinary collaboration, the university engages in a wide array of clinical trials aimed at addressing pressing medical challenges. Its commitment to ethical standards and regulatory compliance ensures the integrity of its research initiatives, while its experienced team of researchers and clinicians work diligently to translate scientific discoveries into practical applications that benefit patients and communities. The University of Valencia is at the forefront of medical research, fostering a culture of excellence and innovation in the pursuit of better healthcare solutions.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials